These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Design, synthesis and anticholinesterase activity of a novel series of 1-benzyl-4-((6-alkoxy-3-oxobenzofuran-2(3H)-ylidene) methyl) pyridinium derivatives. Nadri H; Pirali-Hamedani M; Shekarchi M; Abdollahi M; Sheibani V; Amanlou M; Shafiee A; Foroumadi A Bioorg Med Chem; 2010 Sep; 18(17):6360-6. PubMed ID: 20673725 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors. Wang C; Wu Z; Cai H; Xu S; Liu J; Jiang J; Yao H; Wu X; Xu J Bioorg Med Chem Lett; 2015 Nov; 25(22):5212-6. PubMed ID: 26454504 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors. Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632 [TBL] [Abstract][Full Text] [Related]
7. Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors. Alipour M; Khoobi M; Foroumadi A; Nadri H; Moradi A; Sakhteman A; Ghandi M; Shafiee A Bioorg Med Chem; 2012 Dec; 20(24):7214-22. PubMed ID: 23140986 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors. Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521 [TBL] [Abstract][Full Text] [Related]
9. Novel donepezil-like N-benzylpyridinium salt derivatives as AChE inhibitors and their corresponding dihydropyridine "bio-oxidizable" prodrugs: Synthesis, biological evaluation and structure-activity relationship. Azzouz R; Peauger L; Gembus V; Ţînţaş ML; Sopková-de Oliveira Santos J; Papamicaël C; Levacher V Eur J Med Chem; 2018 Feb; 145():165-190. PubMed ID: 29324339 [TBL] [Abstract][Full Text] [Related]
10. Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. Asadipour A; Alipour M; Jafari M; Khoobi M; Emami S; Nadri H; Sakhteman A; Moradi A; Sheibani V; Homayouni Moghadam F; Shafiee A; Foroumadi A Eur J Med Chem; 2013; 70():623-30. PubMed ID: 24211638 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and Evaluation of Chroman-4-One Linked to N-Benzyl Pyridinium Derivatives as New Acetylcholinesterase Inhibitors. Arab S; Sadat-Ebrahimi SE; Mohammadi-Khanaposhtani M; Moradi A; Nadri H; Mahdavi M; Moghimi S; Asadi M; Firoozpour L; Pirali-Hamedani M; Shafiee A; Foroumadi A Arch Pharm (Weinheim); 2015 Sep; 348(9):643-9. PubMed ID: 26192069 [TBL] [Abstract][Full Text] [Related]
12. Phthalimide-Derived N-Benzylpyridinium Halides Targeting Cholinesterases: Synthesis and Bioactivity of New Potential Anti-Alzheimer's Disease Agents. Saeedi M; Golipoor M; Mahdavi M; Moradi A; Nadri H; Emami S; Foroumadi A; Shafiee A Arch Pharm (Weinheim); 2016 Apr; 349(4):293-301. PubMed ID: 26898241 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-acetylcholinesterase activity of scopoletin derivatives. Khunnawutmanotham N; Chimnoi N; Saparpakorn P; Techasakul S Bioorg Chem; 2016 Apr; 65():137-45. PubMed ID: 26943478 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors. Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208 [TBL] [Abstract][Full Text] [Related]
15. New benzyl pyridinium derivatives bearing 2,4-dioxochroman moiety as potent agents for treatment of Alzheimer's disease: Design, synthesis, biological evaluation, and docking study. Mollazadeh M; Mohammadi-Khanaposhtani M; Zonouzi A; Nadri H; Najafi Z; Larijani B; Mahdavi M Bioorg Chem; 2019 Jun; 87():506-515. PubMed ID: 30928873 [TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel coumarin-pyridinium hybrids: In vitro cholinesterase inhibitory activity. Vafadarnejad F; Mahdavi M; Karimpour-Razkenari E; Edraki N; Sameem B; Khanavi M; Saeedi M; Akbarzadeh T Bioorg Chem; 2018 Apr; 77():311-319. PubMed ID: 29421707 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of edaravone derivatives bearing the Zondagh LS; Malan SF; Joubert J J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1596-1605. PubMed ID: 32779503 [TBL] [Abstract][Full Text] [Related]
18. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease. Luo XT; Wang CM; Liu Y; Huang ZG Eur J Med Chem; 2015 Oct; 103():302-11. PubMed ID: 26363866 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, Biological Evaluation and Molecular Modelling of 2'-Hydroxychalcones as Acetylcholinesterase Inhibitors. Sukumaran SD; Chee CF; Viswanathan G; Buckle MJ; Othman R; Abd Rahman N; Chung LY Molecules; 2016 Jul; 21(7):. PubMed ID: 27455222 [TBL] [Abstract][Full Text] [Related]
20. Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease. Kurt BZ; Gazioglu I; Basile L; Sonmez F; Ginex T; Kucukislamoglu M; Guccione S Eur J Med Chem; 2015 Sep; 102():80-92. PubMed ID: 26244990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]